• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝硬化后乳糜性腹水的管理:一例报告

Management of chylous ascites after liver cirrhosis: A case report.

作者信息

Chen Zong-Qiang, Zeng Shu-Jun, Xu Chun

机构信息

Department of Gastroenterology, Guangdong Medical University, Zhanjiang 524000, Guangdong Province, China.

Department of Gastroenterology, Huizhou Central People's Hospital, Huizhou 516000, Guangdong Province, China.

出版信息

World J Hepatol. 2025 Jan 27;17(1):100797. doi: 10.4254/wjh.v17.i1.100797.

DOI:10.4254/wjh.v17.i1.100797
PMID:39871904
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11736487/
Abstract

BACKGROUND

Chylous ascites is an uncommon condition, occurring in less than 1% of ascites cases. It results from traumatic or obstructive disruption of the lymphatic system, causing the leakage of thoracic or intestinal lymph into the abdominal cavity. This leads to the accumulation of a milky, triglyceride-rich fluid. In adults, malignancy and cirrhosis are the primary causes of chylous ascites. Notably, chylous ascites accounts for only 0.5% to 1% of all cirrhosis-related ascites cases. At present, there is a limited understanding of this condition, and effective timely management in clinical practice remains challenging.

CASE SUMMARY

This case report presents a patient with hepatic cirrhosis complicated by chylous ascites, who had experienced multiple hospitalizations due to abdominal distension. Upon admission, comprehensive examinations and assessments were conducted. The treatment strategy focused on nutritional optimization through a low-sodium, low-fat, and high-protein diet supplemented with medium-chain triglycerides, therapeutic paracentesis, and diuretics. Following a multidisciplinary discussion and thorough evaluation of the patient's condition, surgical indications were confirmed. After informing the patient about the benefits and risks, and obtaining consent, a transjugular intrahepatic portosystemic shunt procedure was performed, successfully alleviating the abdominal swelling symptoms. This article details the clinical characteristics and treatment approach for this uncommon case, summarizing current management methods for hepatic cirrhosis complicated by chylous ascites. The aim is to provide valuable insights for clinicians encountering similar situations.

CONCLUSION

Optimizing nutrition and addressing the underlying cause are essential in the treatment of chylous ascites. When conservative approaches prove ineffective, alternative interventions such as transjugular intrahepatic portosystemic shunt may be considered.

摘要

背景

乳糜性腹水是一种罕见病症,在腹水病例中发生率不到1%。它是由淋巴系统的创伤性或阻塞性破坏引起的,导致胸腔或肠道淋巴液漏入腹腔。这会导致富含甘油三酯的乳状液体积聚。在成年人中,恶性肿瘤和肝硬化是乳糜性腹水的主要病因。值得注意的是,乳糜性腹水仅占所有肝硬化相关腹水病例的0.5%至1%。目前,对这种病症的了解有限,在临床实践中进行有效的及时管理仍然具有挑战性。

病例摘要

本病例报告介绍了一名肝硬化合并乳糜性腹水的患者,该患者因腹胀多次住院。入院后,进行了全面的检查和评估。治疗策略的重点是通过低钠、低脂和高蛋白饮食补充中链甘油三酯来优化营养、进行治疗性腹腔穿刺放液和使用利尿剂。经过多学科讨论并对患者病情进行全面评估后,确认了手术指征。在告知患者益处和风险并获得同意后,进行了经颈静脉肝内门体分流术,成功缓解了腹部肿胀症状。本文详细介绍了这一罕见病例的临床特征和治疗方法,总结了肝硬化合并乳糜性腹水的当前管理方法。目的是为遇到类似情况的临床医生提供有价值的见解。

结论

优化营养和解决根本原因在乳糜性腹水的治疗中至关重要。当保守方法证明无效时,可以考虑诸如经颈静脉肝内门体分流术等替代干预措施。

相似文献

1
Management of chylous ascites after liver cirrhosis: A case report.肝硬化后乳糜性腹水的管理:一例报告
World J Hepatol. 2025 Jan 27;17(1):100797. doi: 10.4254/wjh.v17.i1.100797.
2
Review article: the diagnostic approach and current management of chylous ascites.综述文章:乳糜性腹水的诊断方法与当前治疗
Aliment Pharmacol Ther. 2017 Nov;46(9):816-824. doi: 10.1111/apt.14284. Epub 2017 Sep 11.
3
Refractory Chylous Ascites with Chylothorax and an Umbilical Hernia in a Patient Ineligible for a Transjugular Intrahepatic Portosystemic Shunt.难治性乳糜性腹水伴乳糜性胸腔积液和脐疝,患者不符合经颈静脉肝内门体分流术适应证。
Am J Case Rep. 2020 Aug 31;21:e925026. doi: 10.12659/AJCR.925026.
4
Chylous Ascites: Evaluation and Management.乳糜性腹水:评估与管理
ISRN Hepatol. 2014 Feb 3;2014:240473. doi: 10.1155/2014/240473. eCollection 2014.
5
Use of orlistat (xenical) to treat chylous ascites.使用奥利司他(赛尼可)治疗乳糜性腹水。
J Clin Gastroenterol. 2005 Oct;39(9):831-3. doi: 10.1097/01.mcg.0000177232.51888.2e.
6
Chylous ascites: Case report of a rare presentation of blunt abdominal trauma.乳糜性腹水:钝性腹部创伤罕见表现的病例报告。
Int J Surg Case Rep. 2020;77:799-802. doi: 10.1016/j.ijscr.2020.11.134. Epub 2020 Nov 30.
7
Cirrhosis related chylous ascites successfully treated with TIPS.经颈静脉肝内门体分流术成功治疗肝硬化相关乳糜性腹水
Eur J Gastroenterol Hepatol. 2005 Apr;17(4):463-6. doi: 10.1097/00042737-200504000-00013.
8
Transjugular intrahepatic portosystemic shunt for chylous ascites in a patient with recurrent cirrhosis following liver transplantation.经颈静脉肝内门体分流术治疗肝移植术后复发性肝硬化合并乳糜性腹水患者
Radiol Case Rep. 2016 Nov 18;12(1):84-86. doi: 10.1016/j.radcr.2016.10.010. eCollection 2017 Mar.
9
Chylous Ascites: A Review of Pathogenesis, Diagnosis and Treatment.乳糜性腹水:发病机制、诊断与治疗综述
J Clin Transl Hepatol. 2018 Mar 28;6(1):105-113. doi: 10.14218/JCTH.2017.00035. Epub 2017 Dec 4.
10
Transjugular intrahepatic portosystemic shunt creation as treatment for refractory chylous ascites and chylothorax in a patient with cirrhosis.经颈静脉肝内门体分流术治疗肝硬化患者难治性乳糜性腹水和乳糜胸
J Vasc Interv Radiol. 2004 Jan;15(1 Pt 1):85-9. doi: 10.1097/01.rvi.0000106391.63463.4c.

本文引用的文献

1
The role of transjugular intrahepatic portosystemic shunt in patients with portal hypertension: Advantages and pitfalls.经颈静脉肝内门体分流术在门静脉高压患者中的作用:优势与陷阱。
Clin Mol Hepatol. 2022 Apr;28(2):121-134. doi: 10.3350/cmh.2021.0239. Epub 2021 Sep 27.
2
Lymphatic dysfunction in advanced cirrhosis: Contextual perspective and clinical implications.晚期肝硬化中的淋巴功能障碍:背景视角与临床意义
World J Hepatol. 2021 Mar 27;13(3):300-314. doi: 10.4254/wjh.v13.i3.300.
3
Role of Terlipressin in Cirrhotic Patients with Ascites and without Hepatorenal Syndrome: A Systematic Review of Current Evidence.
特利加压素在肝硬化伴腹水且无肝肾综合征患者中的作用:当前证据的系统评价。
Can J Gastroenterol Hepatol. 2020 Jun 22;2020:5106958. doi: 10.1155/2020/5106958. eCollection 2020.
4
Review article: the diagnostic approach and current management of chylous ascites.综述文章:乳糜性腹水的诊断方法与当前治疗
Aliment Pharmacol Ther. 2017 Nov;46(9):816-824. doi: 10.1111/apt.14284. Epub 2017 Sep 11.
5
Transjugular Intrahepatic Portosystemic Shunt for the Treatment of Chylothorax and Chylous Ascites in Cirrhosis: A Case Report and Systematic Review of the Literature.经颈静脉肝内门体分流术治疗肝硬化患者的乳糜胸和乳糜性腹水:病例报告及文献系统综述
J Vasc Interv Radiol. 2016 Jan;27(1):112-6. doi: 10.1016/j.jvir.2015.09.022.
6
Acute rhabdomyolysis and chylous ascites in a patient with cirrhosis and malignant hepatic tumor.
J Formos Med Assoc. 2014 Feb;113(2):137-8. doi: 10.1016/j.jfma.2011.07.019. Epub 2012 May 22.
7
Effectiveness of therapeutic lymphography on lymphatic leakage.治疗性淋巴造影术对淋巴漏的疗效
Acta Radiol. 2011 Apr 1;52(3):305-11. doi: 10.1258/ar.2010.090356.
8
Lymphangiography in the diagnosis and localization of various chyle leaks.淋巴管造影术在各种乳糜漏的诊断和定位中的应用。
Cardiovasc Intervent Radiol. 2012 Feb;35(1):117-26. doi: 10.1007/s00270-010-0066-x. Epub 2010 Dec 16.
9
The effectiveness of the treatment of octreotide on chylous ascites after liver cirrhosis.奥曲肽治疗肝硬化后乳糜性腹水的疗效
Dig Dis Sci. 2009 Aug;54(8):1783-8. doi: 10.1007/s10620-008-0566-6. Epub 2008 Dec 3.
10
Octreotide in the outpatient therapy of cirrhotic chylous ascites: a case report.奥曲肽用于肝硬化乳糜性腹水的门诊治疗:一例报告
Dig Liver Dis. 2006 Feb;38(2):138-42. doi: 10.1016/j.dld.2005.05.013. Epub 2006 Jan 4.